12 May 2021

Navigating the Adoption of Continuous Pharma Manufacturing Amid Unprecedented Global Challenges

PDF 1.8 MB

In addition to the devastating impact the COVID-19 global pandemic has had on public health, the economy, and the overall quality of our day-to-day lives, it has also exposed significant risks in today’s pharmaceutical supply chain. Improvements in speed to market and quality assurance, among other factors, need to be made to ensure not only the timely delivery of safe and efficacious drugs but also the stability necessary to manage future risks and disruptions.

Content provided by our supplier

Thermo Fisher Scientific Inc.

  • US
  • 2015
    On CPhI since
  • 5000+

Other Content from Thermo Fisher Scientific Inc.